Treating methicillin-resistant Staphylococcus aureus with the drug vancomycin in a home infusion therapy setting

Authors

Joshua L. Webb, Marshall University
Alberto Coustasse, Marshall UniversityFollow
Dennis Emmett, Marshall UniversityFollow

Document Type

Conference Proceeding

Publication Date

3-2012

Abstract

The basic purpose of this paper is to examine the effects the home infusion therapy has on the cost, duration of, and effectiveness of treatment between those individuals under 60 and those 60 and over. The results show that those 60 and over had a slightly higher cost/day. The older age group had slightly smaller treatment duration, then the younger group. The number of adverse effects was small. The results suggest that home infusion therapy appears to be a viable alternative to hospitalization.

Comments

Presented at the Business and Health Administration Association Annual Conference 2012, at the 48th Annual Midwest Business Administration Association International Conference, Chicago, IL., March 28-30, 2012. Joshua L. Webb, Alberto Coustasse and Dennis Emmett gave a PowerPoint presentation, which is included here as a supplement to the conference paper. The conference brochure is online at http://www.mbaainternational.org/pdf/MBAA_Program_2012.pdf.

Copyright 2012 Business and Health Administration Association. Reprinted with permission. PowerPoint copyright 2012 the authors.

Recommended Citation

Webb, J., Coustasse, A., Emmett, D. Treating methicillin-resistant Staphylococcus aureus with the drug vancomycin in a home infusion therapy setting. Business and Health Administration Association Annual Conference 2012. Paper presented at the Business and Health Administration Association (BHAA) Annual Conference 2012, at the 48th Annual Midwest Business Administration Association International Conference. Chicago, Illinois. Mar 2012.